drugset / Trial / NCT07637006

Linzhi Jianghuang Fufang Huoxue Anshen Capsule for Non-alcoholic Fatty Liver

NCT07637006 ↗

Phase 2 Not yet recruiting 180 enrolled Hong Kong Baptist University
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a randomized, double-blinded, placebo-controlled clinical trial aimed at evaluating the efficacy and safety of Linzhi Jianghuang Fufang Huoxue Anshen Capsule (LJF) for non-alcoholic fatty liver.

Timeline

Start
2026-09
Primary completion
2028-07
Completion
2029-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Linzhi Jianghuang Fufang Huoxue Anshen Capsule Traditional medicine (herbal / TCM) 1.2 g Oral